This paper follows a preliminary communication to this Journal two years ago (Sandison, Spencer and Whitelaw, 1954) and gives an account of the fuller experience gained up to the present time with lysergic acid diethylamide in the treatment of mental illness.
No takes yet. Share an insight, caveat, or question.
Sandison et al. (1957) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: